Martino F, Bossotti M, Polastri R, Balcet F, Vasario U
II Divisione di Chirurgia Generale, Ospedale Gradenigo, Torino.
Minerva Med. 1992 Jun;83(6):363-5.
Personal experience in peroperative antibiotic prophylaxis with aztreonam (Azactam) in 81 patients undergoing abdominal surgery of choice is reported. The usefulness, handiness and lack of side-effects of this parenteral drug are reiterated. The incidence of surgical wound infections was 2.5%, while that of associated infections was 6.1%. Considering these results, the use of aztreonam (Azctam) is recommended in peroperative prophylaxis as a drug of choice.
报告了在81例择期腹部手术患者中使用氨曲南（阿兹塔）进行围手术期抗生素预防的个人经验。重申了这种注射用药物的有效性、便利性和无副作用。手术伤口感染发生率为2.5%，而相关感染发生率为6.1%。考虑到这些结果，建议在围手术期预防中使用氨曲南（阿兹塔）作为首选药物。
